webleads-tracker

Pharma Compliance Info The biopharmaceutical's stock took a tumble after the Wall Street Journal asserted that the company has been breaking the Sunshine Act US Sunshine Act

The biopharmaceutical’s stock took a tumble after the Wall Street Journal asserted that the company has been breaking the Sunshine Act

Shares of MiMedx Group (NASDAQ:MDXG), a biopharmaceutical company focused on regenerative medicine, were down 11% as of 3:15 p.m. EST on Friday.Pharma Compliance Info The biopharmaceutical's stock took a tumble after the Wall Street Journal asserted that the company has been breaking the Sunshine Act US Sunshine Act
The drop was spurred by an article published on Thursday stating that the company had failed to make legally required reports of payments that it made to doctors.
The article published by The Wall Street Journal stated that MiMedx had not disclosed its financial relationships with more than 20 doctors — a failure to comply with the Physician Payments Sunshine Act, which was passed in 2013.

To read the article by Brian Feroldi

Check Also

Pharma Compliance Info Senator McCaskill Introduces: The Patient Advocacy Transparency Act of 2018 US Sunshine Act

Senator McCaskill Introduces: The Patient Advocacy Transparency Act of 2018

As a follow-up to Senator Claire McCaskill’s long running opioid investigation and report titled: Fueling …

X